Sentinel Lymph node biopsy for patients with early stage breast cancer update The ASCO recommendations are similar to those proposed in the ABS Summary Statement: Management of the Malignant Axilla in Early Breast Cancer and are supported by the ABS.

The ASCO recommendations are similar to those proposed in the ABS Summary Statement: Management of the Malignant Axilla in Early Breast Cancer and are supported by the ABS.

American Society for Clinical Oncology (ASCO), USA | USA
01.01.2016

Added: 01.02.2018

Classifications: Breast & Oncoplastic Surgery

Keywords: Axilla Sentinel Lymph Node Biopsy/ SLNB